Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Acquired Demyelinating Syndromes of the Central Nervous System in Children: The Importance of Regular Follow-up in the First Year After Onset.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Canavese, Carlotta; Favole, Irene; D'Alessandro, Rossella; Vercellino, Fabiana; Papa, Amanda; Podestà , Barbara; Longaretti, Francesca; Brustia, Francesca; Rampone, Sara; Benedini, Francesca; Giraudo, Mariachiara; Tocchet, Aba
- Source:
Journal of Child Neurology; Aug2023, Vol. 38 Issue 8/9, p537-549, 13p
- Subject Terms:
- Additional Information
- Abstract:
Aim: We reviewed the clinical features of a sample of pediatric acquired demyelinating syndromes with the purpose of determining the appropriate protocol for follow-up after the first episode. Methods: A multicenter retrospective observational study was conducted on a cohort of 40 children diagnosed with a first episode of acquired demyelinating syndrome over the period 2012-2021. Patients were evaluated with clinical and neuroradiologic assessment after 3, 6, and 12 months, with a median follow-up of 4.0 years. Results: At the first acquired demyelinating syndrome episode, 18 patients (45%) were diagnosed with acute disseminated encephalomyelitis, 18 (45%) with clinical isolated syndrome, and 4 (10%) with multiple sclerosis. By month 12, 12 patients (30%) had progressed from an initial diagnosis of acute disseminated encephalomyelitis (2) or clinical isolated syndrome (10) to multiple sclerosis. Of these, 6 had clinical relapse and 6 radiologic relapse only. The first relapse occurred after a median of 3 months. Among the patients who had evolved toward multiple sclerosis, there was a prevalence of females (P =.014), higher oligoclonal bands positivity (P =.009), and older median age (P <.001) as compared with those who had remained stable. Interpretation: Both clinical and radiologic follow-up of children with acquired demyelinating syndromes is crucial, especially during the first year after acute onset, for early identification of multiple sclerosis and prompt initiation of disease-modifying treatment to delay axonal damage and to limit disability. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Journal of Child Neurology is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.